This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karimi-Busheri, F. Articles by Weinfeld, M. Search for Related Content PubMed PubMed Citation Articles by Karimi-Busheri, F. Articles by Weinfeld, M.

Human Polynucleotide Kinase Participates in Repair of DNA Double-Strand Breaks by Nonhomologous End Joining but not Homologous Recombination

Department of Experimental Oncology, Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

Requests for reprints: Michael Weinfeld, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2. Phone: 780-432-8438; Fax: 780-432-8428; E-mail: michaelw{at}cancerboard.ab.ca.

Human polynucleotide kinase (hPNK) is a bifunctional enzyme possessing a 5'-DNA kinase activity and a 3'-phosphatase activity. Studies based on cell extracts and purified proteins have indicated that hPNK can act on single-strand breaks and double-strand breaks (DSB) to restore the termini to the chemical form required for further action by DNA repair polymerases and ligases (i.e., 5'-phosphate and 3'-hydroxyl termini). These studies have revealed that hPNK can bind to XRCC4, and as a result, hPNK has been implicated as a participant in the nonhomologous end joining (NHEJ) pathway for DSB repair. We sought to confirm the role of hPNK in NHEJ in the cellular setting using a genetic approach. hPNK was stably down-regulated by RNA interference expression in M059K glioblastoma cells, which are NHEJ positive, and M059J cells, which are NHEJ deficient due to a lack of DNA-PK catalytic subunit (DNA-PKcs). Whereas depletion of hPNK significantly sensitized M059K cells to ionizing radiation, no additional sensitization was conferred to M059J cells, clearly implying that hPNK operates in the same DNA repair pathway as DNA-PKcs. On the other hand, depletion of hPNK did not increase the level of sister chromatid exchanges, indicating that hPNK is not involved in the homologous recombination DSB repair pathway. We also provide evidence that the action of hPNK in the repair of camptothecin-induced topoisomerase 1 "dead-end" complexes is independent of DNA-PKcs and that hPNK is not involved in the nucleotide excision repair pathway. [Cancer Res 2007;67(14):6619–25]

This article has been cited by other articles:

				M. Lu, R. S. Mani, F. Karimi-Busheri, M. Fanta, H. Wang, D. W. Litchfeld, and M. Weinfeld Independent mechanisms of stimulation of polynucleotide kinase/phosphatase by phosphorylated and non-phosphorylated XRCC1 Nucleic Acids Res., November 12, 2009; (2009) gkp1023v1. [Abstract] [Full Text] [PDF]

				G. K. Freschauf, F. Karimi-Busheri, A. Ulaczyk-Lesanko, T. R. Mereniuk, A. Ahrens, J. M. Koshy, A. Rasouli-Nia, P. Pasarj, C. F.B. Holmes, F. Rininsland, et al. Identification of a Small Molecule Inhibitor of the Human DNA Repair Enzyme Polynucleotide Kinase/Phosphatase Cancer Res., October 1, 2009; 69(19): 7739 - 7746. [Abstract] [Full Text] [PDF]

				S. Burdak-Rothkamm, K. Rothkamm, and K. M. Prise ATM Acts Downstream of ATR in the DNA Damage Response Signaling of Bystander Cells Cancer Res., September 1, 2008; 68(17): 7059 - 7065. [Abstract] [Full Text] [PDF]

				R. S. Mani, M. Fanta, F. Karimi-Busheri, E. Silver, C. A. Virgen, K. W. Caldecott, C. E. Cass, and M. Weinfeld XRCC1 Stimulates Polynucleotide Kinase by Enhancing Its Damage Discrimination and Displacement from DNA Repair Intermediates J. Biol. Chem., September 21, 2007; 282(38): 28004 - 28013. [Abstract] [Full Text] [PDF]